| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Beplate (Douglas K)
|
18.000m | 6.88% | — | Mar 26 2026 |
| 2 |
Denser (Robert J)
|
1.550m | 0.59% | — | Mar 26 2026 |
| 3 |
Thom (Brian David)
|
1.055m | 0.40% | — | Mar 26 2026 |
| 4 |
SlateStone Wealth, LLC
|
161.905k | 0.06% | — | Jun 30 2026 |
| 5 |
Sarver Vrooman Wealth Advisors LLC
|
0.000 | 0.00% | — | Mar 31 2026 |
|
1
Beplate (Douglas K)
|
6.88%
18.000m
|
|
2
Denser (Robert J)
|
0.59%
1.550m
|
|
3
Thom (Brian David)
|
0.40%
1.055m
|
|
4
SlateStone Wealth, LLC
|
0.06%
161.905k
|
|
5
Sarver Vrooman Wealth Advisors LLC
|
0.00%
0.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 7.94% of United Health Products, with Beplate (Douglas K) the biggest at 6.88%, followed by Denser (Robert J) (0.59%) and Thom (Brian David) (0.40%). |
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Nov 07 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Nov 04 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 31 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Oct 26 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Oct 20 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Oct 13 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Nov 07 2026
$182.45
|
|
Sarah Chen
SALES
|
Nov 04 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 31 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Oct 26 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Oct 20 2026
$170.50
|
|
Lisa Park
SALES
|
Oct 13 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


